Inflammation Keeps Us Alive. It's Also Making Us Sick.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Velocity
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
The brief
"Inflammation Keeps Us Alive. It's Also Making Us Sick." is generating significant coverage in the Health category, with 4 articles from 4 distinct sources tracked by PULSE so far.
Outlets currently covering the story include Stuff, eatingwell.com, Yahoo Health and The New York Times. PULSE measures a story's velocity from how quickly new articles appear and how many independent newsrooms join the coverage.
This brief was generated by PULSE's extractive engine from coverage metadata only. The latest headlines from every source are listed below; the velocity chart shows how the story is developing in real time.
Generated by PULSE's extractive engine from coverage metadata only — no AI-written claims. Updated 105d ago.
Quick answers
Why is "Inflammation Keeps Us Alive. It's Also Making Us Sick." trending?
Because 4 independent news sources published 4 articles about it in a short window — a coverage burst PULSE classifies as a trend.
How does PULSE measure this trend?
PULSE scores velocity from the rate of new articles weighted by source diversity, snapshotted hourly. The full method is public on our methodology page.
Is this trend still active?
The status badge on this page updates hourly: rising, peaking, cooling, or archived once coverage stops for 48 hours.
Coverage (4)
- Six things an immunologist wishes Kiwis understood about inflammation Stuff · 107d ago
- 3 Truths & 1 Lie About Chronic Inflammation eatingwell.com · 107d ago
- Chronic Inflammation Can Seriously Harm Your Health. These Simple, Science-Backed Habits Help Reduce It. Yahoo Health · 107d ago
- Inflammation Keeps Us Alive. It's Also Making Us Sick. The New York Times · 107d ago
Topics
Related trends
Heart researchers unpack neutral findings from ZEUS, an anti-inflammatory clinical trial
The ZEUS clinical trial found that the anti-inflammatory drug ziltivekimab did not reduce major cardiovascular events in high-risk patients.
Making sense out of Notre Dame’s No. 11 ranking by the CFP committee
College football analysts debate Notre Dame's No. 11 ranking and Miami's defeat in the latest CFP bracket projections.
Marvell Could Be Making a $115 Billion Mistake With Lumentum Purchase
Marvell Technology's massive $115 billion all-stock acquisition of Lumentum sparks intense debate over AI networking valuations and strategic risk.
People’s New Sexiest Man Alive Is Proving Weirdly Controversial
Noah Wyle has been crowned People magazine's 2026 Sexiest Man Alive, sparking immediate debate across digital media.
5 Mediterranean-Diet Foods That Help Lower Inflammation
Health publications and experts highlight anti-inflammatory dietary strategies and Mediterranean foods.
The Immigration Crackdown Is Making It Much Harder to Build Houses
An intensifying immigration crackdown is creating severe labor shortages and threatening hundreds of thousands of new home completions.